MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

    A. Rosal, A. Strafella, S. Martin (Toronto, Canada)

    Objective: To assess the contribution of Apolipoprotein E4 (APOE4) in Parkinson’s Disease (PD)-related cognitive impairment by analyzing its impact on Gray Matter Volume (GMV). Background:…
  • 2024 International Congress

    Effects of striatal dopamine depletion and altered brain metabolism on Parkinson’s disease

    HS. Yoo, PH. Lee, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To investigate the relationship between striatal dopamine depletion, altered brain metabolism, motor deficits, and cognitive dysfunction in Parkinson’s disease (PD) Background: PD shows degeneration…
  • 2024 International Congress

    Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure

    R. Lopez-Castellanos, S. Factor, R. Blakes (Atlanta, USA)

    Objective: To determine whether Dopamine transporter imaging impacts diagnosis in parkinsonian patients Background: Dopamine transporter imaging (DaTscan) is a diagnostic tool used to assess loss…
  • 2024 International Congress

    Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene

    J. Böhm, J. Uter, R. Lundin, J. Henkel, P. Pramstaller, C. Klein, A. Hicks, M. Heldmann, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating heterozygous Parkin gene (PRKN) mutation carriers to evaluate the potential association of this mutation with an alteration of cognitive control processes. Background: Recessively…
  • 2024 International Congress

    Protocol for Cerebellar Deep Brain Stimulation in Children and Young Adults with Dyskinetic Cerebral Palsy: Combined N-of-1 trials to Assess Safety and Efficacy

    A. Wiltshire, M. San Luciano, C. Oehrn, S. Wang, J. Tolmie, R. Graff, J. Zhu, P. Starr (San Francisco, USA)

    Objective: This study seeks to alleviate severe movement and tone disorders in cerebral palsy (CP) through chronic neuromodulation using deep brain stimulation (DBS), targeting motor…
  • 2024 International Congress

    Raynaud’s Phenomenon and Diaphoresis During Initial Programming of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: A Case Report

    A. Camargo, S. Akkus, J. Jimenez Shahed (Harstdale, USA)

    Objective: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for motor symptoms in advanced Parkinson's disease (PD). However, autonomic side…
  • 2024 International Congress

    Is Neuropsychological Evaluation Needed to Assess DBS Candidacy in Essential Tremor?

    T. Turner, C. Cooper, F. Rodriguez-Porcel, D. Lench, V. Hinson, G. Revuelta (Charleston, USA)

    Objective: In this study we examined frequency of cognitive and psychiatric disorders identified during neuropsychological evaluation for Deep Brain Stimulation (DBS) in patients with Essential…
  • 2024 International Congress

    Feasibility and added value of sensing feature in patients with chronic STN DBS for Parkinson’s disease

    A. Boogers, MB. Justich, M. Montiel, I. Alhashyan, S. Naghdlou, S. Kalia, A. Lozano, RP. Munhoz, A. Fasano (Toronto, Canada)

    Objective: To test the feasibility and usefulness of sensing features in patients undergoing replacement of their implantable pulse generator (IPG). Background: People with Parkinson’s disease…
  • 2024 International Congress

    Levodopa response is an inadequate and often biased correlate of STN-DBS outcomes

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To investigate the reliability of the relationship between levodopa response and subthalamic nucleus (STN) DBS outcomes in Parkinson disease (PD). Background: Levodopa response (LR)…
  • 2024 International Congress

    Clinically implemented sensing-based initial programming of deep brain stimulation for Parkinson’s disease: a retrospective study

    A. Fuentes, B. Swinnen, M. Volz, S. Heath, P. Starr, S. Little, J. Ostrem (Palo Alto, USA)

    Objective: We aimed to assess the feasibility and performance of clinically implemented sensing-based initial deep brain stimulation (DBS) programming for Parkinson’s disease (PD). Background: Initial…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley